Rate and Predictors of Bacteremia in Afebrile Community-Acquired Pneumonia

Although blood cultures (BCs) are the "gold standard" for detecting bacteremia, the utility of BCs in patients with community-acquired pneumonia (CAP) is controversial. This study describes the proportion of patients with CAP and afebrile bacteremia and identifies the clinical characterist...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chest Ročník 157; číslo 3; s. 529
Hlavní autoři: Forstner, Christina, Patchev, Vladimir, Rohde, Gernot, Rupp, Jan, Witzenrath, Martin, Welte, Tobias, Burgmann, Heinz, Pletz, Mathias W
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.03.2020
Témata:
ISSN:1931-3543, 1931-3543
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Although blood cultures (BCs) are the "gold standard" for detecting bacteremia, the utility of BCs in patients with community-acquired pneumonia (CAP) is controversial. This study describes the proportion of patients with CAP and afebrile bacteremia and identifies the clinical characteristics predicting the necessity for BCs in patients who are afebrile. Bacteremia rates were determined in 4,349 patients with CAP enrolled in the multinational cohort study The Competence Network of Community-Acquired Pneumonia (CAPNETZ) and stratified by presence of fever at first patient contact. Independent predictors of bacteremia in patients who were afebrile were determined using logistic regression analysis. Bacteremic pneumonia was present in 190 of 2,116 patients who were febrile (8.9%), 101 of 2,149 patients who were afebrile (4.7%), and one of 23 patients with hypothermia (4.3%). Bacteremia rates increased with the CURB-65 score from 3.5% in patients with CURB-65 score of 0 to 17.1% in patients with CURB-65 score of 4. Patients with afebrile bacteremia exhibited the highest 28-day mortality rate (9.9%). Positive pneumococcal urinary antigen test (adjusted OR [AOR], 4.6; 95% CI, 2.6-8.2), C-reactive protein level > 200 mg/L (AOR, 3.1; 95% CI, 1.9-5.2), and BUN level ≥ 30 mg/dL (AOR, 3.1; 95% CI, 1.9-5.3) were independent positive predictors, and antibiotic pretreatment (AOR, 0.3; 95% CI, 0.1-0.6) was an independent negative predictor of bacteremia in patients who were afebrile. A relevant proportion of patients with bacteremic CAP was afebrile. These patients had an increased mortality rate compared with patients with febrile bacteremia or nonbacteremic pneumonia. Therefore, the relevance of fever as an indicator for BC necessity merits reconsideration.
AbstractList Although blood cultures (BCs) are the "gold standard" for detecting bacteremia, the utility of BCs in patients with community-acquired pneumonia (CAP) is controversial. This study describes the proportion of patients with CAP and afebrile bacteremia and identifies the clinical characteristics predicting the necessity for BCs in patients who are afebrile. Bacteremia rates were determined in 4,349 patients with CAP enrolled in the multinational cohort study The Competence Network of Community-Acquired Pneumonia (CAPNETZ) and stratified by presence of fever at first patient contact. Independent predictors of bacteremia in patients who were afebrile were determined using logistic regression analysis. Bacteremic pneumonia was present in 190 of 2,116 patients who were febrile (8.9%), 101 of 2,149 patients who were afebrile (4.7%), and one of 23 patients with hypothermia (4.3%). Bacteremia rates increased with the CURB-65 score from 3.5% in patients with CURB-65 score of 0 to 17.1% in patients with CURB-65 score of 4. Patients with afebrile bacteremia exhibited the highest 28-day mortality rate (9.9%). Positive pneumococcal urinary antigen test (adjusted OR [AOR], 4.6; 95% CI, 2.6-8.2), C-reactive protein level > 200 mg/L (AOR, 3.1; 95% CI, 1.9-5.2), and BUN level ≥ 30 mg/dL (AOR, 3.1; 95% CI, 1.9-5.3) were independent positive predictors, and antibiotic pretreatment (AOR, 0.3; 95% CI, 0.1-0.6) was an independent negative predictor of bacteremia in patients who were afebrile. A relevant proportion of patients with bacteremic CAP was afebrile. These patients had an increased mortality rate compared with patients with febrile bacteremia or nonbacteremic pneumonia. Therefore, the relevance of fever as an indicator for BC necessity merits reconsideration.
Although blood cultures (BCs) are the "gold standard" for detecting bacteremia, the utility of BCs in patients with community-acquired pneumonia (CAP) is controversial. This study describes the proportion of patients with CAP and afebrile bacteremia and identifies the clinical characteristics predicting the necessity for BCs in patients who are afebrile.BACKGROUNDAlthough blood cultures (BCs) are the "gold standard" for detecting bacteremia, the utility of BCs in patients with community-acquired pneumonia (CAP) is controversial. This study describes the proportion of patients with CAP and afebrile bacteremia and identifies the clinical characteristics predicting the necessity for BCs in patients who are afebrile.Bacteremia rates were determined in 4,349 patients with CAP enrolled in the multinational cohort study The Competence Network of Community-Acquired Pneumonia (CAPNETZ) and stratified by presence of fever at first patient contact. Independent predictors of bacteremia in patients who were afebrile were determined using logistic regression analysis.METHODSBacteremia rates were determined in 4,349 patients with CAP enrolled in the multinational cohort study The Competence Network of Community-Acquired Pneumonia (CAPNETZ) and stratified by presence of fever at first patient contact. Independent predictors of bacteremia in patients who were afebrile were determined using logistic regression analysis.Bacteremic pneumonia was present in 190 of 2,116 patients who were febrile (8.9%), 101 of 2,149 patients who were afebrile (4.7%), and one of 23 patients with hypothermia (4.3%). Bacteremia rates increased with the CURB-65 score from 3.5% in patients with CURB-65 score of 0 to 17.1% in patients with CURB-65 score of 4. Patients with afebrile bacteremia exhibited the highest 28-day mortality rate (9.9%). Positive pneumococcal urinary antigen test (adjusted OR [AOR], 4.6; 95% CI, 2.6-8.2), C-reactive protein level > 200 mg/L (AOR, 3.1; 95% CI, 1.9-5.2), and BUN level ≥ 30 mg/dL (AOR, 3.1; 95% CI, 1.9-5.3) were independent positive predictors, and antibiotic pretreatment (AOR, 0.3; 95% CI, 0.1-0.6) was an independent negative predictor of bacteremia in patients who were afebrile.RESULTSBacteremic pneumonia was present in 190 of 2,116 patients who were febrile (8.9%), 101 of 2,149 patients who were afebrile (4.7%), and one of 23 patients with hypothermia (4.3%). Bacteremia rates increased with the CURB-65 score from 3.5% in patients with CURB-65 score of 0 to 17.1% in patients with CURB-65 score of 4. Patients with afebrile bacteremia exhibited the highest 28-day mortality rate (9.9%). Positive pneumococcal urinary antigen test (adjusted OR [AOR], 4.6; 95% CI, 2.6-8.2), C-reactive protein level > 200 mg/L (AOR, 3.1; 95% CI, 1.9-5.2), and BUN level ≥ 30 mg/dL (AOR, 3.1; 95% CI, 1.9-5.3) were independent positive predictors, and antibiotic pretreatment (AOR, 0.3; 95% CI, 0.1-0.6) was an independent negative predictor of bacteremia in patients who were afebrile.A relevant proportion of patients with bacteremic CAP was afebrile. These patients had an increased mortality rate compared with patients with febrile bacteremia or nonbacteremic pneumonia. Therefore, the relevance of fever as an indicator for BC necessity merits reconsideration.CONCLUSIONSA relevant proportion of patients with bacteremic CAP was afebrile. These patients had an increased mortality rate compared with patients with febrile bacteremia or nonbacteremic pneumonia. Therefore, the relevance of fever as an indicator for BC necessity merits reconsideration.
Author Rohde, Gernot
Patchev, Vladimir
Pletz, Mathias W
Rupp, Jan
Witzenrath, Martin
Burgmann, Heinz
Welte, Tobias
Forstner, Christina
Author_xml – sequence: 1
  givenname: Christina
  surname: Forstner
  fullname: Forstner, Christina
  email: christina.forstner@med.uni-jena.de
  organization: Institute of Infectious Diseases and Infection Control, University Hospital, Jena, Germany; Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria. Electronic address: christina.forstner@med.uni-jena.de
– sequence: 2
  givenname: Vladimir
  surname: Patchev
  fullname: Patchev, Vladimir
  organization: Institute of Infectious Diseases and Infection Control, University Hospital, Jena, Germany
– sequence: 3
  givenname: Gernot
  surname: Rohde
  fullname: Rohde, Gernot
  organization: Medical Department I, Department of Respiratory Medicine, Goethe University Hospital, Frankfurt/Main, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL); CAPNETZ Stiftung, Hannover, Germany
– sequence: 4
  givenname: Jan
  surname: Rupp
  fullname: Rupp, Jan
  organization: CAPNETZ Stiftung, Hannover, Germany; Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein, Lübeck, Germany; German Center for Infection Research (DZIF), partner site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany
– sequence: 5
  givenname: Martin
  surname: Witzenrath
  fullname: Witzenrath, Martin
  organization: CAPNETZ Stiftung, Hannover, Germany; Department of Infectious Diseases and Pulmonary Medicine and the Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
– sequence: 6
  givenname: Tobias
  surname: Welte
  fullname: Welte, Tobias
  organization: Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL); CAPNETZ Stiftung, Hannover, Germany; Department of Pneumology, Hannover Medical School, Hannover, Germany
– sequence: 7
  givenname: Heinz
  surname: Burgmann
  fullname: Burgmann, Heinz
  organization: Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria
– sequence: 8
  givenname: Mathias W
  surname: Pletz
  fullname: Pletz, Mathias W
  organization: Institute of Infectious Diseases and Infection Control, University Hospital, Jena, Germany; CAPNETZ Stiftung, Hannover, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31669433$$D View this record in MEDLINE/PubMed
BookMark eNpNUE1LxDAUDLLifugvECRHL615TZOaY138ZMFF9Fxe2lfM0qa7aXvYf2_BFTzNMMwMzCzZzHeeGLsGEYMAfbeLy2_qhzgRYCYlFkKfsQUYCZFUqZz943O27PudEALA6As2l6C1SaVcsLcPHIijr_g2UOXKoQs972r-gOVAgVqH3Hme12SDa4ivu7YdvRuOUV4eRjdF-NbT2Hbe4SU7r7Hp6eqEK_b19Pi5fok278-v63wTlWmWDVFiSWjCe0QAIbFCo0DV1hqV2ExAaQVpg1qpGrVMVQW6TjM1LYHUKFvbZMVuf3v3oTuM0wNF6_qSmgY9dWNfJBJElkAm9GS9OVlH21JV7INrMRyLv_3JD2AEX08
CitedBy_id crossref_primary_10_1038_s41416_021_01430_w
crossref_primary_10_1002_hem3_29
crossref_primary_10_1093_jacamr_dlae078
crossref_primary_10_3389_fphar_2024_1444439
crossref_primary_10_1007_s15010_021_01605_w
crossref_primary_10_1007_s15010_020_01400_z
crossref_primary_10_3389_fendo_2024_1438700
crossref_primary_10_1016_j_jinf_2022_09_017
crossref_primary_10_1007_s15010_024_02351_5
crossref_primary_10_1016_j_ejim_2022_04_028
crossref_primary_10_3389_fcimb_2022_903682
crossref_primary_10_1016_j_chest_2024_05_005
crossref_primary_10_1186_s12879_021_06450_8
crossref_primary_10_1055_a_1497_0693
crossref_primary_10_1186_s12931_022_02117_3
crossref_primary_10_1007_s15033_021_2749_1
crossref_primary_10_2147_IDR_S394779
crossref_primary_10_1016_j_chest_2020_04_014
crossref_primary_10_1007_s15010_023_02074_z
crossref_primary_10_3390_jcm12123924
crossref_primary_10_1007_s15010_022_01953_1
crossref_primary_10_1016_j_chest_2020_04_021
crossref_primary_10_1016_j_ijid_2024_107312
ContentType Journal Article
Contributor Illig, T
Schaberg, T
Kreuter, M
Dalhoff, K
Rupp, J
Buschmann, H
Hummler, S
Schleenvoigt, B
Pletz, M
Suttorp, N
Naim, J
Hörster, R
Kolditz, M
Arenas Toro, O
Pankow, W
Hauptmeier, B
Krieger, D
Witzenrath, M
Creutz, P
Witte, M
Wallner, M
Freise, J
Wehde, D
Drijkoningen, J
Albrich, W
Frosinski, J
Ravn, P
Winning, J
Herth, F
Baunbaek-Knudsen, G
Knüppel, W
Nawrocki, M
Cornelissen, C
Mikolajewska, A
Thiemig, D
Prediger, M
Stolz, D
Drömann, D
Dreher, M
Langner, S
Vestergaard-Jensen, A
Kroegel, C
Bauer, T
Welte, T
Schmager, S
Klopp, N
Hering, I
Panning, M
Barten, G
Braeken, D
Ewig, S
Schulte-Hubbert, B
Rohde, G
Kröner, W
Contributor_xml – sequence: 1
  givenname: M
  surname: Dreher
  fullname: Dreher, M
– sequence: 2
  givenname: C
  surname: Cornelissen
  fullname: Cornelissen, C
– sequence: 3
  givenname: W
  surname: Knüppel
  fullname: Knüppel, W
– sequence: 4
  givenname: D
  surname: Stolz
  fullname: Stolz, D
– sequence: 5
  givenname: N
  surname: Suttorp
  fullname: Suttorp, N
– sequence: 6
  givenname: M
  surname: Witzenrath
  fullname: Witzenrath, M
– sequence: 7
  givenname: P
  surname: Creutz
  fullname: Creutz, P
– sequence: 8
  givenname: A
  surname: Mikolajewska
  fullname: Mikolajewska, A
– sequence: 9
  givenname: T
  surname: Bauer
  fullname: Bauer, T
– sequence: 10
  givenname: D
  surname: Krieger
  fullname: Krieger, D
– sequence: 11
  givenname: W
  surname: Pankow
  fullname: Pankow, W
– sequence: 12
  givenname: D
  surname: Thiemig
  fullname: Thiemig, D
– sequence: 13
  givenname: B
  surname: Hauptmeier
  fullname: Hauptmeier, B
– sequence: 14
  givenname: S
  surname: Ewig
  fullname: Ewig, S
– sequence: 15
  givenname: D
  surname: Wehde
  fullname: Wehde, D
– sequence: 16
  givenname: M
  surname: Prediger
  fullname: Prediger, M
– sequence: 17
  givenname: S
  surname: Schmager
  fullname: Schmager, S
– sequence: 18
  givenname: M
  surname: Kolditz
  fullname: Kolditz, M
– sequence: 19
  givenname: B
  surname: Schulte-Hubbert
  fullname: Schulte-Hubbert, B
– sequence: 20
  givenname: S
  surname: Langner
  fullname: Langner, S
– sequence: 21
  givenname: W
  surname: Albrich
  fullname: Albrich, W
– sequence: 22
  givenname: T
  surname: Welte
  fullname: Welte, T
– sequence: 23
  givenname: J
  surname: Freise
  fullname: Freise, J
– sequence: 24
  givenname: G
  surname: Barten
  fullname: Barten, G
– sequence: 25
  givenname: O
  surname: Arenas Toro
  fullname: Arenas Toro, O
– sequence: 26
  givenname: M
  surname: Nawrocki
  fullname: Nawrocki, M
– sequence: 27
  givenname: J
  surname: Naim
  fullname: Naim, J
– sequence: 28
  givenname: M
  surname: Witte
  fullname: Witte, M
– sequence: 29
  givenname: W
  surname: Kröner
  fullname: Kröner, W
– sequence: 30
  givenname: T
  surname: Illig
  fullname: Illig, T
– sequence: 31
  givenname: N
  surname: Klopp
  fullname: Klopp, N
– sequence: 32
  givenname: M
  surname: Kreuter
  fullname: Kreuter, M
– sequence: 33
  givenname: F
  surname: Herth
  fullname: Herth, F
– sequence: 34
  givenname: S
  surname: Hummler
  fullname: Hummler, S
– sequence: 35
  givenname: P
  surname: Ravn
  fullname: Ravn, P
– sequence: 36
  givenname: A
  surname: Vestergaard-Jensen
  fullname: Vestergaard-Jensen, A
– sequence: 37
  givenname: G
  surname: Baunbaek-Knudsen
  fullname: Baunbaek-Knudsen, G
– sequence: 38
  givenname: M
  surname: Pletz
  fullname: Pletz, M
– sequence: 39
  givenname: C
  surname: Kroegel
  fullname: Kroegel, C
– sequence: 40
  givenname: J
  surname: Frosinski
  fullname: Frosinski, J
– sequence: 41
  givenname: J
  surname: Winning
  fullname: Winning, J
– sequence: 42
  givenname: B
  surname: Schleenvoigt
  fullname: Schleenvoigt, B
– sequence: 43
  givenname: K
  surname: Dalhoff
  fullname: Dalhoff, K
– sequence: 44
  givenname: J
  surname: Rupp
  fullname: Rupp, J
– sequence: 45
  givenname: R
  surname: Hörster
  fullname: Hörster, R
– sequence: 46
  givenname: D
  surname: Drömann
  fullname: Drömann, D
– sequence: 47
  givenname: G
  surname: Rohde
  fullname: Rohde, G
– sequence: 48
  givenname: J
  surname: Drijkoningen
  fullname: Drijkoningen, J
– sequence: 49
  givenname: D
  surname: Braeken
  fullname: Braeken, D
– sequence: 50
  givenname: H
  surname: Buschmann
  fullname: Buschmann, H
– sequence: 51
  givenname: T
  surname: Schaberg
  fullname: Schaberg, T
– sequence: 52
  givenname: I
  surname: Hering
  fullname: Hering, I
– sequence: 53
  givenname: M
  surname: Panning
  fullname: Panning, M
– sequence: 54
  givenname: M
  surname: Wallner
  fullname: Wallner, M
Copyright Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
CorporateAuthor CAPNETZ Study Group
CorporateAuthor_xml – name: CAPNETZ Study Group
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.chest.2019.10.006
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1931-3543
ExternalDocumentID 31669433
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.1-
.55
.FO
.GJ
.XZ
08P
0R~
18M
1P~
29B
2WC
354
36B
3O-
457
53G
5GY
5RE
5RS
6J9
6PF
7RV
7X7
88E
8AO
8C1
8F7
8FI
8FJ
AAEDT
AAEDW
AAKAS
AAKUH
AALRI
AAWTL
AAXUO
AAYOK
ABDBF
ABDQB
ABJNI
ABLJU
ABMAC
ABOCM
ABUWG
ACBMB
ACGFO
ACGFS
ACGUR
ACUHS
ADBBV
ADVLN
ADZCM
AENEX
AEVXI
AFCTW
AFETI
AFFNX
AFJKZ
AFKRA
AFRHN
AFTJW
AGHFR
AHMBA
AI.
AITUG
AJUYK
AKRWK
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AZQEC
B0M
BCGUY
BENPR
BKEYQ
BKNYI
BPHCQ
BVXVI
C1A
C45
CCPQU
CGR
CS3
CUY
CVF
DU5
EAP
EAS
EBC
EBD
EBS
ECM
EHN
EIF
EJD
EMK
ENC
EPT
ESX
EX3
F5P
FDB
FYUFA
GD~
H13
HMCUK
HX~
HZ~
IH2
INR
J5H
K9-
L7B
LXL
LXN
M0R
M1P
M5~
MJL
MV1
N4W
N9A
NAPCQ
NEJ
NPM
O6.
O9-
OB3
OBH
ODZKP
OFXIZ
OGROG
OHH
OI-
OU.
OVD
OVIDX
P2P
PCD
PHGZT
PQQKQ
PROAC
PSQYO
Q~Q
RIG
ROL
SJN
SSZ
TCP
TEORI
TR2
TUS
TWZ
UKHRP
VH1
W8F
WH7
WOQ
WOW
X7M
XOL
YFH
YHG
YOC
YQJ
Z5R
ZGI
ZRQ
ZXP
ZY1
~8M
7X8
ACVFH
ADCNI
ADGHP
APXCP
EFKBS
ID FETCH-LOGICAL-c477t-2be06ea8aa1103ada9515fbb952b701cb0e69a655fa6345d16f4759311495bfb2
IEDL.DBID 7X8
ISICitedReferencesCount 26
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000518888200024&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1931-3543
IngestDate Thu Oct 02 10:34:25 EDT 2025
Thu Apr 03 07:02:10 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords fever
community-acquired pneumonia (CAP)
predictor
bacteremia
Language English
License Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c477t-2be06ea8aa1103ada9515fbb952b701cb0e69a655fa6345d16f4759311495bfb2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 31669433
PQID 2310721706
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2310721706
pubmed_primary_31669433
PublicationCentury 2000
PublicationDate 2020-03-00
20200301
PublicationDateYYYYMMDD 2020-03-01
PublicationDate_xml – month: 03
  year: 2020
  text: 2020-03-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Chest
PublicationTitleAlternate Chest
PublicationYear 2020
References 32892865 - Chest. 2020 Sep;158(3):1284
32892866 - Chest. 2020 Sep;158(3):1284-1285
References_xml – reference: 32892866 - Chest. 2020 Sep;158(3):1284-1285
– reference: 32892865 - Chest. 2020 Sep;158(3):1284
SSID ssj0001196
Score 2.4527574
Snippet Although blood cultures (BCs) are the "gold standard" for detecting bacteremia, the utility of BCs in patients with community-acquired pneumonia (CAP) is...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 529
SubjectTerms Aged
Bacteremia - epidemiology
Bacteremia - metabolism
Blood Culture
Blood Urea Nitrogen
C-Reactive Protein - metabolism
Cohort Studies
Community-Acquired Infections - epidemiology
Escherichia coli Infections - epidemiology
Escherichia coli Infections - metabolism
Female
Fever - epidemiology
Haemophilus Infections - epidemiology
Haemophilus Infections - metabolism
Humans
Hypothermia - epidemiology
Klebsiella Infections - epidemiology
Klebsiella Infections - metabolism
Logistic Models
Male
Middle Aged
Mortality
Pneumonia - epidemiology
Pneumonia - metabolism
Pneumonia, Pneumococcal - epidemiology
Pneumonia, Pneumococcal - metabolism
Polysaccharides, Bacterial - urine
Retrospective Studies
Risk Factors
Severity of Illness Index
Staphylococcal Infections - epidemiology
Staphylococcal Infections - metabolism
Streptococcal Infections - epidemiology
Streptococcal Infections - metabolism
Viridans Streptococci
Title Rate and Predictors of Bacteremia in Afebrile Community-Acquired Pneumonia
URI https://www.ncbi.nlm.nih.gov/pubmed/31669433
https://www.proquest.com/docview/2310721706
Volume 157
WOSCitedRecordID wos000518888200024&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LSsQwFA3qiLjx_RhfRHAbbd7tSkZxEGGGQRRmV5I0gS5sx3kI_r1J2mFWguCmi0JouaT3npt7eg4AN9pZllCpEJdGISYpQQob36VQXy6xUZLQIppNyOEwHY-zUXvgNmtplcucGBN1UZtwRn4XcIjvVmQi7iefKLhGhelqa6GxDjrUQ5lA6ZLjlVo4xtGfy2MUjChndKk6FPld0Y8qcLuy24be9TvGjLWmv_vft9wDOy3KhL1mW-yDNVsdgK1BO0c_BC-vHmJCVRVwNA03g-UOrB18iNrN9qNUsKxgz_mG2WcN2P5FMv9GPROYw9avq-zCP6xUR-C9__T2-IxaVwVkmJRzRLRNhFWpUr7yU1Uoj7G40zrjRMsEG51YkSnBuVOCMl5g4YImIMWhl9JOk2OwUdWVPQWQk4JzEzTLlGRZyjJifbYkzGmeFkToLrheRin3uzaMIlRl68UsX8WpC06aUOeTRl4jp1iIjFF69ofV52CbhAY4ksIuQMf5b9Zegk3zNS9n06u4Hfx1OBr8AHE5veI
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rate+and+Predictors+of+Bacteremia+in+Afebrile+Community-Acquired+Pneumonia&rft.jtitle=Chest&rft.au=Forstner%2C+Christina&rft.au=Patchev%2C+Vladimir&rft.au=Rohde%2C+Gernot&rft.au=Rupp%2C+Jan&rft.date=2020-03-01&rft.eissn=1931-3543&rft.volume=157&rft.issue=3&rft.spage=529&rft_id=info:doi/10.1016%2Fj.chest.2019.10.006&rft_id=info%3Apmid%2F31669433&rft_id=info%3Apmid%2F31669433&rft.externalDocID=31669433
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-3543&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-3543&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-3543&client=summon